WallStSmart

Coca-Cola European Partners PLC (CCEP)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 449774% more annual revenue ($21.35B vs $4.75M). CCEP leads profitability with a 9.3% profit margin vs -234.5%. CCEP earns a higher WallStSmart Score of 48/100 (D+).

CCEP

Hold

48

out of 100

Grade: D+

Growth: 5.3Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

RKDA

Hold

36

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.0Quality: 5.3
Piotroski: 3/9Altman Z: -58.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CCEP.

RKDAUndervalued (+24.4%)

Margin of Safety

+24.4%

Fair Value

$2.30

Current Price

$0.43

$1.87 discount

UndervaluedFair: $2.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP1 strengths · Avg: 10.0/10
Return on EquityProfitability
42.7%10/10

Every $100 of equity generates 43 in profit

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.473/10

Elevated debt levels

PEG RatioValuation
2.892/10

Expensive relative to growth rate

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$1.14M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-323.1%2/10

ROE of -323.1% — below average capital efficiency

Revenue GrowthGrowth
-0.8%2/10

Revenue declined 0.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

CCEP profiles as a value stock while RKDA is a turnaround play — different risk/reward profiles.

RKDA carries more volatility with a beta of 0.53 — expect wider price swings.

CCEP is growing revenue faster at 4.4% — sustainability is the question.

CCEP generates stronger free cash flow (604M), providing more financial flexibility.

Bottom Line

CCEP scores higher overall (48/100 vs 36/100). RKDA offers better value entry with a 24.4% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?